slides · global inventory
Sequoia Pitch
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 43,093
Current window 23,911-23,940
Pages 1,437
Rows per page 30
Arc
23,911-23,940 of 43,093
27
The chart displays revenue in millions, broken down by Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
28
Houlihan Lokey | Investor Presentation Deck | 33 slidesHoulihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
29
Standard financial disclosure slide for non-GAAP measures.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
30
The slide uses a world map as a subtle background watermark.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
03
Includes both qualitative business milestones and quantitative financial results/guidance.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
The slide uses a three-row structure to categorize company assets and relationships.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
The slide uses a process-like flow to connect technical features to quantitative performance outcomes.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
07
The slide uses a horizontal timeline to track progress against specific technical and production milestones.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
08
Uses a process flow diagram to explain the capital-light manufacturing strategy.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
09
The slide uses a stacked bar chart to illustrate cost structure and contribution margin for different fuel cell configurations.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · SolutionLoop · Zoom In1 hit
12
The slide outlines a progression from Pilot to Ramp-up, detailing truck counts and hydrogen consumption.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
13
The slide uses a funnel-like progression from early engagement to contracted fleets, highlighting specific anchor customers.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
14
The slide uses two distinct visual comparisons: a bar-style timeline for refueling and a bubble-chart style comparison for payload efficiency.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Market Size1 hit
20
Hyzon | Investor Conference Presentation Deck | 24 slidesHyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
21
The table includes revenue, operating expenses, net income, EPS, Adjusted EBITDA, CapEx, cash position, and headcount.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
22
The table provides a detailed breakdown of non-GAAP financial adjustments.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
23
Includes a footnote regarding the exclusion of $8.4 million Orten acquisition cancellation in 3Q 2022.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
24
Includes footnotes regarding legal contingencies and SEC settlements.Hyzon | Investor Conference Presentation Deck | 24 slides · Hyzon
Conference presentation Investor relations Beat · Financials1 hit
09
The slide uses a hub-and-spoke diagram to illustrate the central problem of CAR-T neurotoxicity and its four primary negative outcomes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Includes a cartoon liver character at the bottom.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Includes a footer citing FDA approval precedents for similar patient population sizes.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
12
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
13
The slide uses a standard pharmaceutical pipeline table format.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
14
The slide uses a two-column layout to track progress for two distinct drug programs.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
15
The slide uses a side-by-side comparison of two proprietary platforms.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Immix Biopharma | Investor Presentation Deck | 52 slidesImmix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
17
Includes comparative charts for transduction efficiency and anti-exhaustion capability.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
Includes a comparative table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
19
Immix Biopharma | Investor Presentation Deck | 52 slidesImmix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit